D. Spriggs

Tumor Necrosis Factor Expression by Human Ovarian Carcinoma in Vivo1

Wakamiya, D. Kufe, H. Takeyama, 2006 .

Immunization of ovarian cancer patients with a synthetic Lewisy‐protein conjugate vaccine: A phase 1 trial

M. Peyton, S. Soignet, P. Sabbatini, 2000, International journal of cancer.

Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer

Su-Chun Cheng, M. Nucci, U. Matulonis, 2022, JAMA oncology.

A phase 1 study of KOS-862 (Epothilone D) co-administered with carboplatin (Paraplatin®) in patients with advanced solid tumors

G. Otterson, M. Villalona-Calero, M. Hensley, 2012, Investigational New Drugs.

Effects of dexamethasone on induction of monocytic differentiation in human U‐937 cells by dimethylsulfoxide

T. Nakamura, D. Kufe, S. Kharbanda, 1990, Journal of cellular physiology.

Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment

R. Brentjens, M. Koneru, T. Purdon, 2017, Scientific Reports.